Highmark, Inc. joins numerous payors in creating positive medical policy for WATS3D and opening participation in their networks SUFFERN, N.Y.–(BUSINESS WIRE)–WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to empower physicians to reliably detect Barrett’s esophagus (BE) and esophageal dysplasia to help prevent esophageal cancer, was designated as medically necessary by Highmark, Inc. health … [Read more…]

Physician practices report strong reimbursement rates, lowering accounts receivables, strengthening cash flow ATLANTA–(BUSINESS WIRE)–#RCM—Azalea Health, a leading provider of fully-integrated cloud-based healthcare solutions and services, released today results from its internal customer survey, highlighting how providers are leveraging the company’s revenue cycle management (RCM) services throughout the year. The Azalea RCM Performance Analysis was conducted … [Read more…]

The study, published in PLOS ONE, establishes LiquidHALLMARK’s market-leading sensitivity and identifies actionable biomarkers in majority of cancer patients and 70% of lung cancer patients; Mary Jo Mullen joins the Company as SVP, Commercial to oversee US market growth PALO ALTO, Calif.–(BUSINESS WIRE)–Lucence, the precision oncology company pioneering ultrasensitive liquid biopsy tests, is announcing the … [Read more…]

New Technology Aims to Empower EHR Users with More Efficient Access to Clinical Information at the Point of Care MOBILE, Ala.–(BUSINESS WIRE)–$CPSI—CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced the pilot launch of Quippe Clinical Lens in partnership with Medicomp Systems. Through integration with CPSI’s Patient Data Console, a unique dashboard that presents problem-oriented … [Read more…]

Innovative anesthesia delivery puts women’s health first, saving patients time and reducing cost and risk of unintentional dural puncture, which can lead to severe and chronic headaches ROSELAND, N.J.–(BUSINESS WIRE)–With post epidural side effects becoming more serious than previously known, today Milestone Scientific Inc. announced the availability of its CompuFlo® Epidural instrument in hospitals and … [Read more…]

  NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (NYSE American: ELMD) today announced the results of a third-party, clinical study presented as a clinical abstract poster at the American Thoracic Society International Conference in San Francisco, CA. The study’s key findings reveal that patients who used high frequency chest wall oscillation (“HFCWO”) therapy experienced an improvement in … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Xponential Fitness, Inc. (NYSE: XPOF) (the “Company” or “Xponential Fitness”), the largest global franchisor of boutique fitness brands, today announced Anthony Geisler, Chief Executive Officer; John Meloun, Chief Financial Officer; and Sarah Luna, President, will participate in the following upcoming investor conferences: The Credit Suisse HALO Investment Summit to be held May 24-25, … [Read more…]

CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that executive management will participate in the following investor events: Todd Koning, Chief Financial Officer, will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at … [Read more…]

BERWYN, Pa.–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. (“Virpax”) (NASDAQ: VRPX), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Tuesday, May 24th starting at 7:00 a.m. ET through Friday, May 27th. Anthony P. Mack, Chairman & CEO of … [Read more…]

-Expanded clinical development presence is expected to accelerate activities for THIO-101 Phase 2 Trial for NSCLC- CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), announced today that the company has established two wholly-owned subsidiaries in Romania and Australia to broaden and accelerate its global development plan … [Read more…]